Enveric Biosciences, Inc. (ENVB) vs Kiora Pharmaceuticals, Inc. (KPRX)
- Enveric Biosciences, Inc. ENVB 1.42 +1.43%
- Kiora Pharmaceuticals, Inc. KPRX 1.42 −5.33%
Enveric Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are both Biotechnology companies. Enveric Biosciences, Inc. and Kiora Pharmaceuticals, Inc. are of similar size ($6.6M and $6.3M). Kiora Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 983.7% against −13.9%. Across the 14 metrics below, Kiora Pharmaceuticals, Inc. leads on 8 and Enveric Biosciences, Inc. on 6.
Valuation
Profitability
| Metric | ENVB | KPRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 85.06% | 68.51% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (235.48%) | (56.36%) | (51.96%) |
| Return on assets | (193.53%) | (39.43%) | (46.06%) |
| Return on invested capital | 0.00% | (44,053.91%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack